Shares of Bausch Health Companies Inc. (TSE:BHC - Get Free Report) traded up 0.9% during trading on Thursday . The stock traded as high as C$8.97 and last traded at C$8.91. 218,073 shares were traded during mid-day trading, a decline of 40% from the average session volume of 361,495 shares. The stock had previously closed at C$8.83.
Bausch Health Companies Stock Performance
The company's fifty day moving average price is C$7.63 and its 200 day moving average price is C$8.75. The company has a market cap of C$2.32 billion, a PE ratio of -13.04, a P/E/G ratio of 0.21 and a beta of 0.77. The company has a debt-to-equity ratio of -1,831.94, a current ratio of 1.19 and a quick ratio of 0.58.
Insider Transactions at Bausch Health Companies
In related news, Director John Paulson acquired 1,782,030 shares of the firm's stock in a transaction that occurred on Friday, June 13th. The stock was acquired at an average price of C$8.14 per share, for a total transaction of C$14,501,803.73. Insiders have bought a total of 3,553,401 shares of company stock worth $27,087,675 in the last three months. Company insiders own 11.28% of the company's stock.
Bausch Health Companies Company Profile
(
Get Free Report)
Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Bausch Health Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bausch Health Companies wasn't on the list.
While Bausch Health Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
